Glutamine: the emperor or his clothes?
- PMID:11533293
- DOI: 10.1093/jn/131.9.2449S
Glutamine: the emperor or his clothes?
Abstract
In this introduction to the Proceedings of the Symposium on Glutamine, we consider various lines of evidence that might potentially lead to an answer to the question posed in the title. We begin with a short summary of the multiple functions of glutamine, which are extensive and, superficially at least, equally as impressive as those of glutamate. However, each of these amino acids may serve an equivalent role in some of these functions due to their ready metabolic interconversion. We raise the question whether glutamine is of primordial or rudimentary significance or whether it is a product of somebody else's existence. Thus, there is a short account of the prebiotic events of evolution that led to the appearance of glutamine and life on Earth. In doing this, it then appears that glutamine is a rather schizophrenic molecule, stable and thermodynamically reliable in biochemical environments, but labile in chemical ones. We then turn to the involvement of glutamine in mammalian N (nitrogen) commerce, with initial emphasis on the nitrogen cycle on Earth, then N transport and N excretion, before assessing its contribution to carbon/energy or C/E commerce. We hypothesize that, in addition to its utilization in immune cell function and in normal intestinal tissues, glutamine is a particularly key anapleurotic and energy-yielding substrate in conditions of hypoxia, anoxia and dysoxia. It also serves as a quantitatively important gluconeogenic metabolite under normal postabsorptive conditions. We postulate that in certain conditions, this carbon-energy econometric function might be by-passed with ornithine. In conclusion, the answer to the question above depends on the context, and this point will receive elaboration in many of the individual contributions that collaborate to form these Proceedings.
Similar articles
- Glutamine or glutamate release by the liver constitutes a major mechanism for nitrogen salvage.Rémésy C, Moundras C, Morand C, Demigné C.Rémésy C, et al.Am J Physiol. 1997 Feb;272(2 Pt 1):G257-64. doi: 10.1152/ajpgi.1997.272.2.G257.Am J Physiol. 1997.PMID:9124349
- Glutamine and glutamate--their central role in cell metabolism and function.Newsholme P, Procopio J, Lima MM, Pithon-Curi TC, Curi R.Newsholme P, et al.Cell Biochem Funct. 2003 Mar;21(1):1-9. doi: 10.1002/cbf.1003.Cell Biochem Funct. 2003.PMID:12579515Review.
- The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer.Bak LK, Schousboe A, Waagepetersen HS.Bak LK, et al.J Neurochem. 2006 Aug;98(3):641-53. doi: 10.1111/j.1471-4159.2006.03913.x. Epub 2006 Jun 19.J Neurochem. 2006.PMID:16787421Review.
- Glutamine and glutamate as vital metabolites.Newsholme P, Lima MM, Procopio J, Pithon-Curi TC, Doi SQ, Bazotte RB, Curi R.Newsholme P, et al.Braz J Med Biol Res. 2003 Feb;36(2):153-63. doi: 10.1590/s0100-879x2003000200002. Epub 2003 Jan 29.Braz J Med Biol Res. 2003.PMID:12563517Review.
- Glutamine and the bowel.Reeds PJ, Burrin DG.Reeds PJ, et al.J Nutr. 2001 Sep;131(9 Suppl):2505S-8S; discussion 2523S-4S. doi: 10.1093/jn/131.9.2505S.J Nutr. 2001.PMID:11533302Review.
Cited by
- Effects of Ferroptosis on Cardiovascular Diseases.Xu J, Pi J, Zhang Y, Zhou J, Zhang S, Wu S.Xu J, et al.Mediators Inflamm. 2023 May 4;2023:6653202. doi: 10.1155/2023/6653202. eCollection 2023.Mediators Inflamm. 2023.PMID:37181809Free PMC article.Review.
- Current topical trends and novel therapeutic approaches and delivery systems for oral mucositis management.Al-Taie A, Al-Shohani AD, Albasry Z, Altaee A.Al-Taie A, et al.J Pharm Bioallied Sci. 2020 Apr-Jun;12(2):94-101. doi: 10.4103/jpbs.JPBS_198_19. Epub 2020 Apr 10.J Pharm Bioallied Sci. 2020.PMID:32742107Free PMC article.Review.
- Effect of intravenous amino acids on glutamine and protein kinetics in low-birth-weight preterm infants during the immediate neonatal period.Kadrofske MM, Parimi PS, Gruca LL, Kalhan SC.Kadrofske MM, et al.Am J Physiol Endocrinol Metab. 2006 Apr;290(4):E622-30. doi: 10.1152/ajpendo.00274.2005. Epub 2005 Nov 1.Am J Physiol Endocrinol Metab. 2006.PMID:16263773Free PMC article.Clinical Trial.
- Targeting hepatic glutaminase activity to ameliorate hyperglycemia.Miller RA, Shi Y, Lu W, Pirman DA, Jatkar A, Blatnik M, Wu H, Cárdenas C, Wan M, Foskett JK, Park JO, Zhang Y, Holland WL, Rabinowitz JD, Birnbaum MJ.Miller RA, et al.Nat Med. 2018 May;24(4):518-524. doi: 10.1038/nm.4514. Epub 2018 Mar 26.Nat Med. 2018.PMID:29578539Free PMC article.
- Glutaminase-1 stimulates the proliferation, migration, and survival of human endothelial cells.Peyton KJ, Liu XM, Yu Y, Yates B, Behnammanesh G, Durante W.Peyton KJ, et al.Biochem Pharmacol. 2018 Oct;156:204-214. doi: 10.1016/j.bcp.2018.08.032. Epub 2018 Aug 23.Biochem Pharmacol. 2018.PMID:30144404Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical